{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:07:08Z","timestamp":1777871228507,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuroblastoma, the most common type of pediatric extracranial solid tumor, causes 10% of childhood cancer deaths. Despite intensive multimodal treatment, the outcomes of high-risk neuroblastoma remain poor. We urgently need to develop new therapies with safe long-term toxicity profiles for rapid testing in clinical trials. Drug repurposing is a promising approach to meet these needs. Here, we investigated disulfiram, a safe and successful chronic alcoholism treatment with known anticancer and epigenetic effects. Disulfiram efficiently induced cell cycle arrest and decreased the viability of six human neuroblastoma cell lines at half-maximal inhibitory concentrations up to 20 times lower than its peak clinical plasma level in patients treated for chronic alcoholism. Disulfiram shifted neuroblastoma transcriptome, decreasing MYCN levels and activating neuronal differentiation. Consistently, disulfiram significantly reduced the protein level of lysine acetyltransferase 2A (KAT2A), drastically reducing acetylation of its target residues on histone H3. To investigate disulfiram\u2019s anticancer effects in an in vivo model of high-risk neuroblastoma, we developed a disulfiram-loaded emulsion to deliver the highly liposoluble drug. Treatment with the emulsion significantly delayed neuroblastoma progression in mice. These results identify KAT2A as a novel target of disulfiram, which directly impacts neuroblastoma epigenetics and is a promising candidate for repurposing to treat pediatric neuroblastoma.<\/jats:p>","DOI":"10.1038\/s41598-023-43219-2","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T10:02:09Z","timestamp":1696068129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water\/oil emulsion"],"prefix":"10.1038","volume":"13","author":[{"given":"Annie","family":"Beaudry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Jacques-Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Darracq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sgarioto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresita Rode","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathie","family":"B\u00e9land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"McGraw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Marois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"St-Onge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sinnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Banquy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00ebl J.-M.","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"43219_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41588-021-00806-1","volume":"53","author":"S Jansky","year":"2021","unstructured":"Jansky, S. et al. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. Nat. Genet. 53, 683\u2013693 (2021).","journal-title":"Nat. Genet."},{"key":"43219_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/cancers8010013","volume":"8","author":"LL Stafman","year":"2016","unstructured":"Stafman, L. L. & Beierle, E. A. Cell proliferation in neuroblastoma. Cancers (Basel) 8, 13 (2016).","journal-title":"Cancers (Basel)"},{"key":"43219_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00383-012-3239-7","volume":"29","author":"R Domingo-Fernandez","year":"2013","unstructured":"Domingo-Fernandez, R., Watters, K., Piskareva, O., Stallings, R. L. & Bray, I. The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis. Pediatr. Surg. Int. 29, 101\u2013119 (2013).","journal-title":"Pediatr. Surg. Int."},{"key":"43219_CR4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrclinonc.2014.168","volume":"11","author":"GM Brodeur","year":"2014","unstructured":"Brodeur, G. M. & Bagatell, R. Mechanisms of neuroblastoma regression. Nat. Rev. Clin. Oncol. 11, 704\u2013713 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"43219_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cncr.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse, K. R. & Maris, J. M. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 122, 20\u201333 (2016).","journal-title":"Cancer"},{"key":"43219_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur, G. M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer. 3, 203\u2013216 (2003).","journal-title":"Nat. Rev. Cancer."},{"key":"43219_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","volume":"8","author":"B Qiu","year":"2022","unstructured":"Qiu, B. & Matthay, K. K. Advancing therapy for neuroblastoma. Nat. Rev. Clin. Oncol. 8, 515 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"43219_CR8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","volume":"313","author":"RC Seeger","year":"1985","unstructured":"Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111\u20131116 (1985).","journal-title":"N. Engl. J. Med."},{"key":"43219_CR9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"GM Brodeur","year":"1984","unstructured":"Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121\u20131124 (1984).","journal-title":"Science"},{"key":"43219_CR10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1541-7786.MCR-13-0536","volume":"12","author":"H Beltran","year":"2014","unstructured":"Beltran, H. The N-myc oncogene: Maximizing its targets, regulation, and therapeutic potential. Mol. Cancer Res. 12, 815\u2013822 (2014).","journal-title":"Mol. Cancer Res."},{"key":"43219_CR11","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","volume":"16","author":"WA Weiss","year":"1997","unstructured":"Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985\u20132995 (1997).","journal-title":"EMBO J."},{"key":"43219_CR12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.624079","volume":"10","author":"J Otte","year":"2021","unstructured":"Otte, J., Dyberg, C., Pepich, A. & Johnsen, J. I. MYCN function in neuroblastoma development. Front. Oncol. 10, 624079 (2021).","journal-title":"Front. Oncol."},{"key":"43219_CR13","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1038\/s41388-019-0967-3","volume":"38","author":"A Alptekin","year":"2019","unstructured":"Alptekin, A. et al. Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity. Oncogene 38, 7504\u20137520 (2019).","journal-title":"Oncogene"},{"key":"43219_CR14","first-page":"9725","volume":"12","author":"YF Guo","year":"2020","unstructured":"Guo, Y. F. et al. Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN-amplified neuroblastoma growth. Sci. Transl. Med. 12, 9725 (2020).","journal-title":"Sci. Transl. Med."},{"key":"43219_CR15","first-page":"1","volume":"3","author":"S He","year":"2013","unstructured":"He, S., Liu, Z., Oh, D. Y. & Thiele, C. J. MYCN and the epigenome. Front. Oncol. 3, 1 (2013).","journal-title":"Front. Oncol."},{"key":"43219_CR16","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/sj.emboj.7601152","volume":"25","author":"PS Knoepfler","year":"2006","unstructured":"Knoepfler, P. S. et al. Myc influences global chromatin structure. EMBO J. 25, 2723\u20132734 (2006).","journal-title":"EMBO J."},{"key":"43219_CR17","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.18632\/oncotarget.27226","volume":"10","author":"AT Farria","year":"2019","unstructured":"Farria, A. T., Mustachio, L. M., Akdemir, Z. H. C. & Dent, S. Y. R. GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways. Oncotarget 10, 5847\u20135858 (2019).","journal-title":"Oncotarget"},{"key":"43219_CR18","first-page":"1830","volume":"9","author":"LM Mustachio","year":"2019","unstructured":"Mustachio, L. M., Roszik, J., Farria, A. T., Guerra, K. & Dent, S. Y. Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer. Am. J. Cancer Res. 9, 1830\u20131845 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"43219_CR19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/0008-5472.CAN-19-3652","volume":"80","author":"LM Mustachio","year":"2020","unstructured":"Mustachio, L. M., Roszik, J., Farria, A. & Dent, S. Y. R. Targeting the SAGA and ATAC transcriptional coactivator complexes in MYC-driven cancers. Cancer Res. 80, 1905\u20131911 (2020).","journal-title":"Cancer Res."},{"key":"43219_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-12-0418","volume":"3","author":"A Puissant","year":"2013","unstructured":"Puissant, A. et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 3, 308\u2013323 (2013).","journal-title":"Cancer Discov."},{"key":"43219_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-019-0376-8","volume":"25","author":"HP Mohammad","year":"2019","unstructured":"Mohammad, H. P., Barbash, O. & Creasy, C. L. Targeting epigenetic modifications in cancer therapy: Erasing the roadmap to cancer. Nat. Med. 25, 403\u2013418 (2019).","journal-title":"Nat. Med."},{"key":"43219_CR22","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.51","volume":"4","author":"JM Gajer","year":"2015","unstructured":"Gajer, J. M. et al. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis 4, e137 (2015).","journal-title":"Oncogenesis"},{"key":"43219_CR23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrclinonc.2014.149","volume":"11","author":"PC Adamson","year":"2014","unstructured":"Adamson, P. C., Houghton, P. J., Perilongo, G. & Pritchard-Jones, K. Drug discovery in paediatric oncology: Roadblocks to progress. Nat. Rev. Clin. Oncol. 11, 732\u2013739 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"43219_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrclinonc.2015.169","volume":"12","author":"F Bertolini","year":"2015","unstructured":"Bertolini, F., Sukhatme, V. P. & Bouche, G. Drug repurposing in oncology\u2014Patient and health systems opportunities. Nat. Rev. Clin. Oncol. 12, 732\u2013742 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"43219_CR25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-14-2391","volume":"76","author":"NJ Raynal","year":"2016","unstructured":"Raynal, N. J. et al. Targeting calcium signaling induces epigenetic reactivation of tumor suppressor genes in cancer. Cancer Res. 76, 1494\u20131505 (2016).","journal-title":"Cancer Res."},{"key":"43219_CR26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1535-7163.MCT-16-0588","volume":"16","author":"NJ Raynal","year":"2017","unstructured":"Raynal, N. J. et al. Repositioning FDA-approved drugs in combination with epigenetic drugs to reprogram colon cancer epigenome. Mol. Cancer Ther. 16, 397\u2013407 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"43219_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","volume":"369","author":"B Johansson","year":"1992","unstructured":"Johansson, B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr. Scand. Suppl. 369, 15\u201326 (1992).","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"43219_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002018-199920050-00003","volume":"20","author":"J Chick","year":"1999","unstructured":"Chick, J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf. 20, 427\u2013435 (1999).","journal-title":"Drug Saf."},{"key":"43219_CR29","doi-asserted-by":"crossref","first-page":"58516","DOI":"10.18632\/oncotarget.11305","volume":"7","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Targeting ALDH1A1 by disulfiram\/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells. Oncotarget 7, 58516\u201358530 (2016).","journal-title":"Oncotarget"},{"key":"43219_CR30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/neuonc\/nou305","volume":"17","author":"SA Choi","year":"2015","unstructured":"Choi, S. A. et al. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid\/rhabdoid tumors. Neuro Oncol. 17, 810\u2013821 (2015).","journal-title":"Neuro Oncol."},{"key":"43219_CR31","first-page":"197","volume":"1","author":"D Cen","year":"2002","unstructured":"Cen, D. et al. Disulfiram induces apoptosis in human melanoma cells: A redox-related process. Mol. Cancer Ther. 1, 197\u2013204 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"43219_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott, Z. et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552, 194\u2013199 (2017).","journal-title":"Nature"},{"key":"43219_CR33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.18632\/oncotarget.707","volume":"3","author":"P Hothi","year":"2012","unstructured":"Hothi, P. et al. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells. Oncotarget 3, 1124\u20131136 (2012).","journal-title":"Oncotarget"},{"key":"43219_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","volume":"6","author":"P Dufour","year":"1993","unstructured":"Dufour, P. et al. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy 6, 9\u201312 (1993).","journal-title":"Biotherapy"},{"key":"43219_CR35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","volume":"20","author":"H Nechushtan","year":"2015","unstructured":"Nechushtan, H. et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist 20, 366\u2013367 (2015).","journal-title":"Oncologist"},{"key":"43219_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1039\/b504392a","volume":"1","author":"ZE Sauna","year":"2005","unstructured":"Sauna, Z. E., Shukla, S. & Ambudkar, S. V. Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. Mol. Biosyst. 1, 127\u2013134 (2005).","journal-title":"Mol. Biosyst."},{"key":"43219_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","volume":"21","author":"PA Jones","year":"1999","unstructured":"Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nat. Genet. 21, 163\u2013167 (1999).","journal-title":"Nat. Genet."},{"key":"43219_CR38","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-11-3248","volume":"72","author":"NJ Raynal","year":"2012","unstructured":"Raynal, N. J. et al. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res. 72, 1170 (2012).","journal-title":"Cancer Res."},{"key":"43219_CR39","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1074\/mcp.M114.038174","volume":"13","author":"AM Cieniewicz","year":"2014","unstructured":"Cieniewicz, A. M. et al. The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3. Mol. Cell Proteom. 13, 2896\u20132910 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"43219_CR40","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"43219_CR41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/database\/baw100","volume":"2016","author":"AD Rouillard","year":"2016","unstructured":"Rouillard, A. D. et al. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) 2016, 100 (2016).","journal-title":"Database (Oxford)"},{"key":"43219_CR42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcis.2008.10.077","volume":"330","author":"L Wang","year":"2009","unstructured":"Wang, L., Dong, J., Chen, J., Eastoe, J. & Li, X. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 330, 443\u2013448 (2009).","journal-title":"J. Colloid Interface Sci."},{"key":"43219_CR43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0268-005X(01)00091-1","volume":"15","author":"X Huang","year":"2001","unstructured":"Huang, X., Kakuda, Y. & Cui, W. Hydrocolloids in emulsions: Particle size distribution and interfacial activity. Food Hydrocolloids 15, 533\u2013542 (2001).","journal-title":"Food Hydrocolloids"},{"key":"43219_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(00)00314-X","volume":"70","author":"V Muguet","year":"2001","unstructured":"Muguet, V. et al. Formulation of shear rate sensitive multiple emulsions. J. Control Release 70, 37\u201349 (2001).","journal-title":"J. Control Release"},{"key":"43219_CR45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/tx00040a008","volume":"7","author":"L Jin","year":"1994","unstructured":"Jin, L., Davis, M. R., Hu, P. & Baillie, T. A. Identification of novel glutathione conjugates of disulfiram and diethyldithiocarbamate in rat bile by liquid chromatography-tandem mass spectrometry. Evidence for metabolic activation of disulfiram in vivo. Chem. Res. Toxicol. 7, 526\u2013533 (1994).","journal-title":"Chem. Res. Toxicol."},{"key":"43219_CR46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2967\/jnumed.112.113324","volume":"54","author":"C Rae","year":"2013","unstructured":"Rae, C. et al. The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. J. Nucl. Med. 54, 953\u2013960 (2013).","journal-title":"J. Nucl. Med."},{"key":"43219_CR47","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-21-0385","volume":"12","author":"AD Durbin","year":"2022","unstructured":"Durbin, A. D. et al. EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discov. 12, 730\u2013751 (2022).","journal-title":"Cancer Discov."},{"key":"43219_CR48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"43219_CR49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"43219_CR50","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43219-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:24:44Z","timestamp":1700479484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43219-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43219-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16443"}}